Acyclovir-resistant varicella-zoster virus keratitis in an immunocompetent patient

Journal of Clinical Virology

Volumn 58, Issue 1, 2013, Pages 318-320

  Gueudry, J ^a   Boutolleau, D ^b   Gueudin, M ^a   Burrel, S ^b   Miri, A ^a   Bodaghi, B ^b   Muraine, M ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Acyclovir; Cornea; Drug resistance; Herpetic keratitis; Varicella zoster virus

Indexed keywords

ACICLOVIR; ALPHA2B INTERFERON; CORTICOSTEROID; CYCLOSPORIN; DNA POLYMERASE; FOSCARNET; VALACICLOVIR;

ADULT; AMINO ACID SEQUENCE; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FRAMESHIFT MUTATION; HERPES SIMPLEX KERATITIS; HERPES ZOSTER; HOSPITALIZATION; HUMAN; INTRAOCULAR HYPERTENSION; MAINTENANCE THERAPY; MALE; MEDICATION COMPLIANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOP CODON; SYSTEMIC THERAPY; VARICELLA ZOSTER VIRUS KERATITIS;

EID: 84881499625     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.04.024     Document Type: Article

References (14)

1. Duan R., de Vries R.D., Osterhaus A.D., Remeijer L., Verjans G.M. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Dis 2008, 198:659-663.
2. Sauerbrei A., Taut J., Zell R., Wutzler P. Resistance testing of clinical varicella-zoster virus strains. Antiviral Res 2011, 90:242-247.
3. Chern K.C., Conrad D., Holland G.N., Holsclaw D.S., Schwartz L.K., Margolis T.P. Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol 1998, 116:1011-1017.
4. Margolis T.P., Milner M.S., Shama A., Hodge W., Seiff S. Herpes zoster ophthalmicus in patients with human immunodeficiency virus infection. Am J Ophthalmol 1998, 125:285-291.
5. Bodaghi B., Mougin C., Michelson S., Agut H., Dighiero P., Offret H., et al. Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene. Exp Eye Res 2000, 71:353-359.
6. Lepisto A.J., Frank G.M., Hendricks R.L. How herpes simplex virus type 1 rescinds corneal privilege. Chem Immunol Allergy 2007, 92:203-212.
7. Brink A.A., van Gelder M., Wolffs P.F., Bruggeman C.A., van Loo I.H. Compartmentalization of acyclovir-resistant varicella zoster virus: implications for sampling in molecular diagnostics. Clin Infect Dis 2011, 52:982-987.
8. Lewis G.W. Zoster sine herpete. Br Med J 1958, 2:418-421.
9. Silverstein B.E., Chandler D., Neger R., Margolis T.P. Disciform keratitis: a case of herpes zoster sine herpete. Am J Ophthalmol 1997, 123:254-255.
10. Wilhelmus K.R. The treatment of herpes simplex virus epithelial keratitis. Trans Am Ophthalmol Soc 2000, 98:505-532.
11. Winston D.J., Eron L.J., Ho M., Pazin G., Kessler H., Pottage J.C., et al. Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer. Am J Med 1988, 85:147-151.
12. Koyano S., Suzutani T., Yoshida I., Azuma M. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. Antimicrob Agents Chemother 1996, 40:920-923.
13. Duan R., de Vries R.D., van Dun J.M., van Loenen F.B., Osterhaus A.D., Remeijer L., et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis 2009, 200:1402-1414.
14. van Velzen M., van Loenen F.B., Meesters R.J., de Graaf M., Remeijer L., Luider T.M., et al. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals. J Infect Dis 2012, 205:1539-1543.